Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06511661

Prognostic Significance of the Uncertain Resection in NSCLC

Prognostic Significance of the Uncertain Resection Based on the Extent of Nodal Dissection for Non-small Cell Lung Cancer: A Propensity Score Matching Retrospective Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
3,783 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The concept of residual tumor classification proposed by the Union for International Cancer Control (UICC) was used to assess the completeness of surgical resection, and non-small cell lung cancer (NSCLC) patients with incomplete resection were more likely to occur recurrence, leading to significantly poor survival. But this R classification only refers to the surgical margin and neglects other factors associated with surgical quality, such as the extent of lymph node dissection (LND). Therefore, the International Association for the Study of Lung Cancer (IASLC) proposed the definition of uncertain resection \[R(un)\], which includes the suboptimal extent of LND. However, the clinical significance of R(un) is still controversial. On the one hand, some researches demonstrated that R(un) had definite prognostic significance, with R(un) survival stratifying between R0 and R1. On the other hand, some studies indicated that in early-stage NSCLC, the suboptimal extent of LND had no impact on survival, and the concept of R(un) might be insignificant in these patients. Even in those studies supporting the prognostic significance of R(un), which kind of patients is suitable for R(un) was still unclear. Thus, the investigators explore the impact of the R(un) on the long-term survival of patients with NSCLC using a large cohort in China, to identify those patients who could really benefit from the LND required by the R0 classification proposed by IASLC.

Conditions

Interventions

TypeNameDescription
PROCEDUREComplete lymphadenectomyAt least 3 N1 stations and 3 N2 stations are examined during surgery, including station 7.
PROCEDUREIncomplete lymphadenectomyLess than 3 N1 stations or 3 N2 stations are examined during surgery, or those without station 7 lymph node dissection.

Timeline

Start date
2024-07-16
Primary completion
2025-07-01
Completion
2025-07-01
First posted
2024-07-22
Last updated
2024-07-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06511661. Inclusion in this directory is not an endorsement.